| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |